Literature DB >> 21388985

Ablation of weak emphysematous visceral pleura by an ultrasonically activated device for spontaneous pneumothorax.

Kazuhito Funai1, Kazuya Suzuki, Kei Shimizu, Norihiko Shiiya.   

Abstract

Staple bullectomy is widely performed for the thoracoscopic treatment of spontaneous pneumothorax. When weak emphysematous change was observed to extend to the whole pleura around the localized bulla, weak emphysematous pleura always remain around the stapler after bullectomy. Such cases along with weak pleural surfaces around staplers belong to the groups at high risk of postoperative recurrence. We performed thoracoscopic ablation using an ultrasonically activated device (USAD) for such lesions and studied the efficacy. From April 2002 to December 2006, a total of 85 surgeries for spontaneous pneumothorax were performed in this hospital, of which 34 cases underwent ablation with a USAD for a weak pleural surface. No complications due to ablation were observed. Recurrence was observed in four subjects, but the cause of recurrence was the regeneration of a bulla outside the range of the ablation and was unrelated to the ablation itself. Moreover, significant white pleural thickening was observed at the ablation sites, demonstrating a stiffening effect of the weak visceral pleura. Ablation using a USAD is a safe and easy operative method, and it is an appropriate operative system as a stiffening procedure for a visceral pleura.

Entities:  

Mesh:

Year:  2011        PMID: 21388985     DOI: 10.1510/icvts.2010.264044

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  1 in total

1.  Prevention of Polyglycolic Acid-Induced Peritoneal Adhesions Using Alginate in a Rat Model.

Authors:  Mari Matoba; Ayumi Hashimoto; Ayumi Tanzawa; Taichi Orikasa; Junki Ikeda; Yoshizumi Iwame; Yuki Ozamoto; Rie Abe; Hiroe Miyamoto; Chiko Yoshida; Toru Hashimoto; Hiroko Torii; Hideki Takamori; Shinichiro Morita; Hiroyuki Tsujimoto; Akeo Hagiwara
Journal:  Biomed Res Int       Date:  2015-05-21       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.